The BioInteliSense study found that the company's device was able to cut hospitalisations and alert clinicians ahead of adverse events. The post BioInteliSense remote cardiac device cuts hospital time in trial appeared first on Medical Device Network.
BioIntellisense is a Colorado-based SaaS platform that offers solutions such as health monitoring and algorithmic clinical insights for the healthcare sector.